PRGO Q4 2024 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q4 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.1B-1.6% YoY

Gross Profit

$386M33.9% margin

Operating Income

$114M10.0% margin

Net Income

-$45M-3.9% margin

EPS (Diluted)

$-0.32

QoQ Revenue Growth

+4.7%

Cash Flow

Operating Cash Flow

$313M

Free Cash Flow

$275M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$9.6B

Total Liabilities

$5.3B

Stockholders' Equity

$4.3B

Cash & Equivalents

$559M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.2B	-1.6%
Gross Profit	$386M	$427M	-9.7%
Operating Income	$114M	-$16M	+832.1%
Net Income	-$45M	-$32M	-37.8%

Revenue Segments

Consumer Self-Care Americas

$744M65%

Consumer Self-Care International

$394M35%

Geographic Segments

UNITED STATES

$732M64%

Europe

$379M33%

Other Geographical Areas

$27M2%

IRELAND

$13M1%